Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barré syndrome.
about
The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritisBiomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be ExploredBiomarkers of postoperative delirium and cognitive dysfunctionInflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention.Monitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinicTransthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma.Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients.Glycoproteomics in neurodegenerative diseases.The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis.Preliminary proteomic analysis of human serum from patients with laryngeal carcinoma.The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids.Quantitative proteomics reveals Piccolo as a candidate serological correlate of recovery from Guillain-Barré syndrome.Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders.Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid.Cerebrospinal fluid proteomics reveals potential pathogenic changes in the brains of SIV-infected monkeys.Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome.
P2860
Q21328672-784E713F-561D-42CA-8C93-6C39EF9CB441Q26785669-B86F640C-7726-403D-A206-F02B60065FB7Q26830796-08D608F8-9AB8-4CE8-B251-02C0A28FFF42Q27322544-80E100EB-B3D7-4C2B-929C-0109FB25CAA6Q28483618-3F674344-B5B6-44E3-9F26-C8A42C590356Q33358097-70AB82E1-8A14-4E3E-B706-32BCA3D0B46AQ33497345-581C11F1-A1EE-4A91-B977-7E27587C5E56Q33563387-99464232-E471-4CE7-BFB5-249C728923BDQ33960847-DB30854C-164E-4E1A-AFFD-8C8CFB837588Q34039085-3AC2AA84-83C4-4E8C-B345-C8FEF0CCBA59Q34677183-23E642AC-0EC6-44F3-BB84-F48DD155EA29Q37688817-C17A40C5-B338-43E8-828E-5A4D125C3CE2Q37691267-00438BC0-E70B-4233-9852-1EDB206BA907Q38844925-AA8712D1-418A-4B26-BF35-830987B5B85AQ42979507-EF732FCB-D057-4447-9561-07AED414A372Q51376386-2365E24F-95C0-458B-8186-7B8D531EE258
P2860
Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barré syndrome.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Comparative proteomics analysi ...... with Guillain-Barré syndrome.
@ast
Comparative proteomics analysi ...... with Guillain-Barré syndrome.
@en
type
label
Comparative proteomics analysi ...... with Guillain-Barré syndrome.
@ast
Comparative proteomics analysi ...... with Guillain-Barré syndrome.
@en
prefLabel
Comparative proteomics analysi ...... with Guillain-Barré syndrome.
@ast
Comparative proteomics analysi ...... with Guillain-Barré syndrome.
@en
P2093
P2860
P1476
Comparative proteomics analysi ...... with Guillain-Barré syndrome.
@en
P2093
Fu-Jun Liu
Shi-Lian Liu
Shu-Mei Bai
Yan-Jiang Qin
Yin-Rong Yang
Zhao-Yu Qin
Zhe-Yu Chen
P2860
P2888
P304
P356
10.1007/S10571-007-9257-7
P577
2008-03-15T00:00:00Z
P6179
1026495417